James Schultz

Array ( [id] => 8278544 [patent_doc_number] => 20120172417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'System And Method For Identifying And Applying Peripheral Treatment Mechanisms For Disease' [patent_app_type] => utility [patent_app_number] => 13/238647 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6607 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13238647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8202156 [patent_doc_number] => 20120124685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR GENE EXPRESSION AND CHROMATIN PROFILING OF INDIVIDUAL CELL TYPES WITHIN A TISSUE' [patent_app_type] => utility [patent_app_number] => 13/234109 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 42618 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20120124685.pdf [firstpage_image] =>[orig_patent_app_number] => 13234109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043631 [patent_doc_number] => 20120071558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'COMPOSITIONS OF VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/231649 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16616 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071558.pdf [firstpage_image] =>[orig_patent_app_number] => 13231649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807948 [patent_doc_number] => 20120058902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'METHOD OF MEASURING ADAPTIVE IMMUNITY' [patent_app_type] => utility [patent_app_number] => 13/217126 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28930 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058902.pdf [firstpage_image] =>[orig_patent_app_number] => 13217126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10547408 [patent_doc_number] => 09272008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Oncolytic measles virus' [patent_app_type] => utility [patent_app_number] => 13/818053 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 12531 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8672735 [patent_doc_number] => 20130047273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'Genetically altered animal specimen and related methods' [patent_app_type] => utility [patent_app_number] => 13/136945 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3210 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776543 [patent_doc_number] => 20120039990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Liposome Compositions and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/208902 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 10769 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039990.pdf [firstpage_image] =>[orig_patent_app_number] => 13208902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869093 [patent_doc_number] => 08956865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Methods of growing an embryo to a blastocyst stage of development' [patent_app_type] => utility [patent_app_number] => 13/816311 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4921 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9645476 [patent_doc_number] => 20140223588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'A2M FRAGMENTS AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/234503 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8210100 [patent_doc_number] => 20120129261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Transcriptome Transfer Produces Cellular Phenotype Conversion' [patent_app_type] => utility [patent_app_number] => 13/186232 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16267 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129261.pdf [firstpage_image] =>[orig_patent_app_number] => 13186232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657387 [patent_doc_number] => 20110306656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Biologically tolerated low molecular weight polyethylenimines' [patent_app_type] => utility [patent_app_number] => 13/185436 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6725 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306656.pdf [firstpage_image] =>[orig_patent_app_number] => 13185436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977244 [patent_doc_number] => 20130210675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 13/811136 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7884 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567981 [patent_doc_number] => 20110288044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Modulation of sodium channels by nicotinamide adenine dinucleotide' [patent_app_type] => utility [patent_app_number] => 13/067953 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10170 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288044.pdf [firstpage_image] =>[orig_patent_app_number] => 13067953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573058 [patent_doc_number] => 20110268714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'CD34 Stem Cell-Related Methods and Compositions' [patent_app_type] => utility [patent_app_number] => 13/179374 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18178 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268714.pdf [firstpage_image] =>[orig_patent_app_number] => 13179374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453867 [patent_doc_number] => 20120264814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis)' [patent_app_type] => utility [patent_app_number] => 13/162367 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4372 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003028 [patent_doc_number] => 20130224153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'RECOMBINANT LACTOBACILLUS WITH DECREASED LIPOTEICHOIC ACID TO REDUCE INFLAMMATORY RESPONSES' [patent_app_type] => utility [patent_app_number] => 13/805037 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530014 [patent_doc_number] => 08753883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Treatment of psoriasis using placental stem cells' [patent_app_type] => utility [patent_app_number] => 13/107778 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 31 [patent_no_of_words] => 48770 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586335 [patent_doc_number] => 20110280845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'TREATMENT OF RHEUMATOID ARTHRITIS USING PLACENTAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/107727 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49162 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280845.pdf [firstpage_image] =>[orig_patent_app_number] => 13107727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579702 [patent_doc_number] => 20110293585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/091921 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18452 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293585.pdf [firstpage_image] =>[orig_patent_app_number] => 13091921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487695 [patent_doc_number] => 20110236495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTI-CANCER NANOPARTICLE COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/073270 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236495.pdf [firstpage_image] =>[orig_patent_app_number] => 13073270 [rel_patent_id] =>[rel_patent_doc_number] =>)